Baidu Stock Drops Nearly 20% on $16.2B Impairment Shock
Baidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...
When To Choose Bonds Over Stocks For Retirement
Learn when bonds may outperform stocks for retirement, with practical timing cues and risk considerations.
24,889 articlesSaas Firm with Nearly $1B ARR Faces Investor Exit Amid Slide
When a major investor exits a growing SaaS company, the move can shake confidence and the stock. This article examine...
Treasure Hunter Freed After a Decade: Ship of Gold Saga Rebounds
A once-celebrated treasure hunter exits federal custody after a decade behind bars, as investors weigh the legal fall...
Uber Stock Down Just: Is This a Buy Opportunity Now?
Uber stock has slipped about 12% in three months, trading near $74 after a strong run. This article breaks down what’...
Your First Next) Rental: A Step‑By‑Step Guide for 2026
Thinking about your first next) rental in 2026? This practical guide breaks down financing, deal analysis, and smart ...
NVIDIA Stock Buy? Key Factors for Investors
NVIDIA dominates AI data centers and high-end GPUs, but is the stock a buy right now? This guide weighs growth driver...
AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
This High-Yield Lender Paying Nearly $0.50 Quarterly Has Plummeted 51%, but One Fund Just Made a Big Bet
When a trusted income vehicle slumps by half, the question isn’t just about yield—it’s about safety, value, and the b...
Microsoft: Stock Avoid Once-In-A-Decade or Buy Opportunity
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
Jabil (JBL) 2026 Earnings: Q2 Outlook and Insights
As JBL gears up for its 2026 earnings season, this guide breaks down what to expect from the Q2 call, how to read the...
Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
InMode (INMD) 2026 Earnings: Strategy, Outlook & Risks
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status